Growth Metrics

Integra Lifesciences Holdings (IART) Capital Expenditures Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.64%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.49%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 10.17%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 16.83%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.81%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.35%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.08%
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn 2.71%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.71%
Dec 31, 2025 5.99%
Sep 30, 2025 18.30%
Jun 30, 2025 28.90%
Mar 31, 2025 45.83%
Dec 31, 2024 2.57%
Sep 30, 2024 59.65%
Jun 30, 2024 64.83%
Mar 31, 2024 32.32%
Dec 31, 2023 42.79%
Sep 30, 2023 24.81%
Jun 30, 2023 29.15%
Mar 31, 2023 -6.04%
Dec 31, 2022 -13.32%
Sep 30, 2022 -12.34%
Jun 30, 2022 -18.94%
Mar 31, 2022 -16.62%
Dec 31, 2021 2.21%
Sep 30, 2021 -24.11%
Jun 30, 2021 -30.78%
Mar 31, 2021 -24.30%
Dec 31, 2020 -14.95%
Sep 30, 2020 -4.80%
Jun 30, 2020 -17.43%
Mar 31, 2020 21.58%
Dec 31, 2019 1.55%
Sep 30, 2019 24.91%
Jun 30, 2019 28.80%
Mar 31, 2019 13.87%
Dec 31, 2018 25.16%
Sep 30, 2018 45.96%
Jun 30, 2018 27.62%
Mar 31, 2018 42.39%
Dec 31, 2017 6.84%
Sep 30, 2017 6.70%
Jun 30, 2017 11.07%
Mar 31, 2017 -6.75%
Dec 31, 2016 66.65%
Sep 30, 2016 -19.25%
Jun 30, 2016 -15.34%
Mar 31, 2016 0.13%
Dec 31, 2015 -19.03%
Sep 30, 2015 -35.22%
Jun 30, 2015 -12.23%
Mar 31, 2015 -20.00%
Dec 31, 2014 -4.86%
Sep 30, 2014 -19.37%
Jun 30, 2014 9.04%
Mar 31, 2014 24.16%
Dec 31, 2013 -36.92%
Sep 30, 2013 22.50%
Jun 30, 2013 -8.25%
Mar 31, 2013 56.40%
Dec 31, 2012 29.78%
Sep 30, 2012 51.40%